EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An endogenous human peptide derived from α1-antitrypsin as a novel pharmacological inhibitor of Bordetella pertussis toxin

Stefanie Lietz, Lena-Marie Sokolowski, Alexander Beyschlag, Helena Rosenau, Annika Siewert, Armando A Rodríguez Alfonso, Nico Preising, Ludger Ständker, Sebastian Wiese, Janet Köhler, Gilbert Weidinger, Jan Münch und 3 weitere

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-025-04744-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Stefanie Lietz und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm University Medical Center, 89081, Ulm, Germ…. Hauptthemen laut MEDLINE: alpha 1-Antitrypsin, Pertussis Toxin, Bordetella pertussis, Peptides. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DFG, Deutsche Forschungsgemeinschaft, Universitätsklinikum Ulm.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pertussis, also known as whooping cough, is a highly infectious respiratory disease caused by the bacterium Bordetella pertussis . The bacterial virulence factor, pertussis toxin (PT), is associated with the manifestation of the characteristic symptoms of pertussis and the severe form of this disease. Increasing case numbers and the lack of treatment options highlight the need to develop novel pharmacological strategies, e.g., the generation of specific PT inhibitors. Recently, we identified the endogenous human protein α 1 -antitrypsin (α 1 AT) as an inhibitor of PT from a screening of a human hemofiltrate protein/peptide library. In the present work, we tested an in-house α 1 AT peptide bank to identify an α 1 AT region with anti-PT activity. Then, we compared the sequences of the positive hits from the peptide bank with all known α 1 AT fragments in the hemofiltrate samples to find new active peptides. In total, 36 peptides were tested for their PT inhibition, leading to the identification of an endogenous α 1 AT fragment, α 1 AT HF, derived from hemofiltrate with anti-PT activity. This peptide had no toxic effects on HeLa cells and in vivo on zebrafish embryos, rendering it an attractive lead compound for further evaluation to treat pertussis in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha 1-AntitrypsinPertussis ToxinBordetella pertussisPeptidesPeptide FragmentsHumansAnimalsZebrafish

Stichwörter der Autor:innen

Bordetella pertussisEndogenous peptidesEndogenous proteinsPertussis toxinToxin inhibitorα1-antitrypsin

Substanzen

alpha 1-AntitrypsinPertussis ToxinPeptidesPeptide Fragments

Autor:innen und Institutionen

  • Institute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm University Medical Center, 89081, Ulm, Germany.
  • Core Facility Functional Peptidomics, Ulm University Medical Center, 89081, Ulm, Germany.
  • Core Unit Mass Spectrometry and Proteomics, Ulm University Medical Center, 89081, Ulm, Germany.
  • Institute of Biochemistry and Molecular Biology, Ulm University, 89081, Ulm, Germany.
  • Institute of Molecular Virology, Ulm University Medical Center, 89081, Ulm, Germany.
  • Institute of Biomedicine, University of Turku, 20520, Turku, Finland.

Förderung

  • DFG
  • Deutsche Forschungsgemeinschaft
  • Universitätsklinikum Ulm

Zitieren

APA

Lietz, S., Sokolowski, L. M., Beyschlag, A., Rosenau, H., Siewert, A., Alfonso, A. A. R., Preising, N., Ständker, L., Wiese, S., Köhler, J., Weidinger, G., Münch, J., Pulliainen, A. T., Ernst, K., & Barth, H. (2025). An endogenous human peptide derived from α1-antitrypsin as a novel pharmacological inhibitor of Bordetella pertussis toxin. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04744-1

Vancouver

Lietz S, Sokolowski LM, Beyschlag A, Rosenau H, Siewert A, Alfonso AAR, et al. An endogenous human peptide derived from α1-antitrypsin as a novel pharmacological inhibitor of Bordetella pertussis toxin. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04744-1

BibTeX
@article{Lietz2025,
  author = {Lietz, Stefanie and Sokolowski, Lena-Marie and Beyschlag, Alexander and Rosenau, Helena and Siewert, Annika and Alfonso, Armando A Rodríguez and Preising, Nico and Ständker, Ludger and Wiese, Sebastian and Köhler, Janet and Weidinger, Gilbert and Münch, Jan and Pulliainen, Arto T and Ernst, Katharina and Barth, Holger},
  title = {An endogenous human peptide derived from α1-antitrypsin as a novel pharmacological inhibitor of Bordetella pertussis toxin},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-025-04744-1}
}
Kostenlos starten →